对新冠疫苗的严重过敏反应——声明及实际影响
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences.
作者信息
Kleine-Tebbe Jörg, Klimek Ludger, Hamelmann Eckard, Pfaar Oliver, Taube Christian, Wagenmann Martin, Werfel Thomas, Worm Margitta
机构信息
Allergy and Asthma Center Westend, Berlin.
Center for Rhinology and Allergology of the ENT University Clinic Mannheim, Wiesbaden.
出版信息
Allergol Select. 2021 Jan 5;5:26-28. doi: 10.5414/ALX02215E. eCollection 2021.
Abstract
No abstract available.
摘要
无摘要。
相似文献
1
Severe allergic reactions to the COVID-19 vaccine - statement and practical consequences.对新冠疫苗的严重过敏反应——声明及实际影响
Allergol Select. 2021 Jan 5;5:26-28. doi: 10.5414/ALX02215E. eCollection 2021.
2
Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines.使用 COVID-19 疫苗皮内皮肤试验评估接种辉瑞 BNT162b2 疫苗后的即刻过敏反应。
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2677-2684. doi: 10.1016/j.jaip.2022.08.010. Epub 2022 Aug 13.
3
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.嗜碱性粒细胞活化试验评估报告对 BNT162b2 mRNA COVID-19 疫苗过敏反应患者的价值。
Allergy. 2022 Jul;77(7):2067-2079. doi: 10.1111/all.15148. Epub 2021 Oct 31.
4
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.高过敏风险成年人接种辉瑞-BioNTech COVID-19 疫苗后的过敏反应发生率。
JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.
5
Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions.辉瑞BNT162b2诱导的速发型疫苗超敏反应中的过敏毒素补体5a
Vaccines (Basel). 2023 May 23;11(6):1020. doi: 10.3390/vaccines11061020.
6
Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.曾有对聚乙二醇即刻过敏反应的患者可以安全地接种 BNT162b2 mRNA COVID-19 疫苗。
Intern Med J. 2022 Oct;52(10):1818-1820. doi: 10.1111/imj.15821. Epub 2022 Oct 6.
7
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.COVID-19 疫苗接种在接受过敏原免疫治疗（AIT）或生物制剂治疗的患者中的应用——EAACI 建议。
Allergy. 2022 Aug;77(8):2313-2336. doi: 10.1111/all.15252. Epub 2022 Mar 18.
8
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).英国和美国接种辉瑞/生物科技公司新冠疫苗后出现的严重过敏反应：德国过敏学会立场声明：德国过敏症专科医生医学协会（AeDA）、德国过敏与临床免疫学会（DGAKI）以及儿童过敏与环境医学学会（GPA）
Allergo J Int. 2021;30(2):51-55. doi: 10.1007/s40629-020-00160-4. Epub 2021 Feb 24.
9
Endotyping of IgE-Mediated Polyethylene Glycol and/or Polysorbate 80 Allergy.IgE 介导的聚乙二醇和/或聚山梨酯 80 过敏的表型分型。
J Allergy Clin Immunol Pract. 2023 Oct;11(10):3146-3160. doi: 10.1016/j.jaip.2023.06.031. Epub 2023 Jun 26.
10
Allergy to PEG (polyethylene glycol) - sensitivity of basophil activation test with COVID-19 mRNA-vaccine BNT162B2.对聚乙二醇（PEG）过敏 - 新冠mRNA疫苗BNT162B2的嗜碱性粒细胞活化试验敏感性
Hum Vaccin Immunother. 2024 Dec 31;20(1):2312600. doi: 10.1080/21645515.2024.2312600. Epub 2024 Feb 5.
引用本文的文献
1
Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran.新型冠状病毒肺炎（COVID-19）住院患者、门诊患者的会诊重症和非重症病例的皮肤黏膜表现以及疫苗相关皮肤病：来自伊朗两个综合COVID-19中心的临床图谱及大型原创研究
Dermatol Reports. 2023 May 23;15(2):9473. doi: 10.4081/dr.2023.9473. eCollection 2023 Jun 7.
2
Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary Angioedema.抗SARS-CoV-2 mRNA疫苗在一组遗传性血管性水肿患者中的免疫原性和安全性
Vaccines (Basel). 2023 Jan 18;11(2):215. doi: 10.3390/vaccines11020215.
3
Adverse Effects of COVID-19 Vaccination: Machine Learning and Statistical Approach to Identify and Classify Incidences of Morbidity and Postvaccination Reactogenicity.新冠疫苗接种的不良反应：用于识别和分类发病情况及接种后反应原性的机器学习和统计方法
Healthcare (Basel). 2022 Dec 22;11(1):31. doi: 10.3390/healthcare11010031.
4
SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders.SARS-CoV-2 疫苗：类型、作用原理及其对血栓和胃肠道紊乱的影响。
Appl Biochem Biotechnol. 2023 Feb;195(2):1541-1573. doi: 10.1007/s12010-022-04181-3. Epub 2022 Oct 12.
5
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations.面向新型基于纳米的SARS-CoV-2及其关注变体疫苗平台：进展、挑战与局限
J Drug Deliv Sci Technol. 2022 Oct;76:103762. doi: 10.1016/j.jddst.2022.103762. Epub 2022 Sep 8.
6
[Not Available].[无可用内容]。
Allergo J. 2022;31(2):16-31. doi: 10.1007/s15007-022-4980-4. Epub 2022 Mar 21.
7
Vaccines Against COVID-19: A Review.新型冠状病毒肺炎疫苗综述
Vaccines (Basel). 2022 Mar 10;10(3):414. doi: 10.3390/vaccines10030414.
8
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.一项关于 COVID-19 疫苗接种后黏膜皮肤表现的系统评价和关于重要免疫介导性皮肤病疫苗接种的专家建议。
Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11.
9
A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes.PBPK 模型再现了抗聚乙二醇抗体介导的聚乙二醇脂质体清除的早期动力学。
J Control Release. 2022 Mar;343:518-527. doi: 10.1016/j.jconrel.2022.01.022. Epub 2022 Jan 21.
10
Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus.使用进入抑制剂肽靶向病毒融合前体：以严重急性呼吸综合征冠状病毒2和甲型流感病毒为例
Int J Pept Res Ther. 2022;28(1):42. doi: 10.1007/s10989-021-10357-y. Epub 2022 Jan 3.
本文引用的文献
1
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).英国和美国接种辉瑞/生物科技公司新冠疫苗后出现的严重过敏反应：德国过敏学会立场声明：德国过敏症专科医生医学协会（AeDA）、德国过敏与临床免疫学会（DGAKI）以及儿童过敏与环境医学学会（GPA）
Allergo J Int. 2021;30(2):51-55. doi: 10.1007/s40629-020-00160-4. Epub 2021 Feb 24.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol.与聚乙二醇相关的过敏反应中的抗聚乙二醇IgE
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1731-1733.e3. doi: 10.1016/j.jaip.2020.11.011. Epub 2020 Nov 17.
4
Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis).聚乙二醇引起的全身性过敏反应（过敏症）。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):670-675. doi: 10.1016/j.jaip.2020.09.029. Epub 2020 Oct 1.
5
A case of severe immediate type reaction to macrogol and polysorbate 60 after intravaginal drug application.一例阴道用药后对聚乙二醇和聚山梨酯60发生严重速发型反应的病例。
Eur J Dermatol. 2019 Jun 1;29(3):329-331. doi: 10.1684/ejd.2019.3541.
6
[Not Available].[不可用]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1.
7
Polyethylene glycol as a cause of anaphylaxis.聚乙二醇作为过敏反应的一个原因。
Allergy Asthma Clin Immunol. 2016 Dec 13;12:67. doi: 10.1186/s13223-016-0172-7. eCollection 2016.
8
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population.分析普通人群中预先存在的针对聚乙二醇（PEG）的 IgG 和 IgM 抗体。
Anal Chem. 2016 Dec 6;88(23):11804-11812. doi: 10.1021/acs.analchem.6b03437. Epub 2016 Nov 16.
9
Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.脂质体和脂质体包裹的血红蛋白在猪体内引起的血流动力学变化：脂质体假性过敏心肺反应的模型。补体的作用以及可溶性CR1和抗C5a抗体的抑制作用。
Circulation. 1999 May 4;99(17):2302-9. doi: 10.1161/01.cir.99.17.2302.
Zotero 插件